Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 14, 2016
Event: Entry into a Material Definitive Agreement (Underwriting Agreement) with Barclays Capital Inc. and certain Selling Stockholders.
Key Financial Metrics and Transaction Details
This filing reports a specific capital transaction rather than periodic financial performance metrics (revenue, profit, cash flow, or margins are not included in this 8-K).
- Shares Sold by Stockholders: 2,500,000 shares of Common Stock.
- Price Per Share: $15.68.
- Company Share Repurchase: 500,000 shares purchased from the Underwriter.
- Total Repurchase Cost: $7,840,000.
- Funding Source: Cash on hand.
- Expected Closing Date: November 18, 2016.
Material Changes and Transaction Structure
The Company entered into an Underwriting Agreement where Selling Stockholders agreed to sell shares to the Underwriter. Simultaneously, the Company agreed to purchase 500,000 shares from the Underwriter at the same price paid by the Underwriter to the Selling Stockholders. This repurchase is part of a stock repurchase program authorized by the Board of Directors in November 2016. The sale was conducted pursuant to a Registration Statement on Form S-3.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, outlook, or management commentary on future operations. The document notes customary representations, warranties, covenants, and indemnification provisions within the Underwriting Agreement. No specific risks or contingencies beyond the standard terms of the agreement are detailed in this summary text.
Key Facts for Investor Verification
- Verify the impact of the $7.84 million cash outflow for the share repurchase on the Company's current liquidity position.
- Confirm the identity of the "Selling Stockholders" and the percentage of total outstanding shares they are selling (2.5 million shares).
- Review the full Underwriting Agreement (Exhibit 1.1) for specific lock-up periods or other covenants affecting future trading.
- Check subsequent filings to confirm the transaction closed on the expected date of November 18, 2016.